These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38150285)

  • 1. Longitudinal adherence to annual colorectal cancer screening among Black persons living in the United States enrolled in a community-based randomized trial.
    Arevalo M; Sutton SK; Abdulla R; Christy SM; Meade CD; Roetzheim RG; Gwede CK
    Cancer; 2024 May; 130(9):1684-1692. PubMed ID: 38150285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A community-based trial of educational interventions with fecal immunochemical tests for colorectal cancer screening uptake among blacks in community settings.
    Christy SM; Davis SN; Williams KR; Zhao X; Govindaraju SK; Quinn GP; Vadaparampil ST; Lin HY; Sutton SK; Roethzeim RR; Shibata D; Meade CD; Gwede CK
    Cancer; 2016 Nov; 122(21):3288-3296. PubMed ID: 27420119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics.
    Davis SN; Christy SM; Chavarria EA; Abdulla R; Sutton SK; Schmidt AR; Vadaparampil ST; Quinn GP; Simmons VN; Ufondu CB; Ravindra C; Schultz I; Roetzheim RG; Shibata D; Meade CD; Gwede CK
    Cancer; 2017 Apr; 123(8):1390-1400. PubMed ID: 27906448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the Durability of Colorectal Cancer Screening Awareness and Health Beliefs Among Medically Underserved Patients: Baseline to 12 months Post-Intervention.
    Christy SM; Sutton SK; Gwede CK; Chavarria EA; Davis SN; Abdulla R; Schultz I; Roetzheim R; Shibata D; Meade CD
    J Cancer Educ; 2019 Apr; 34(2):297-303. PubMed ID: 29177920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.
    Singal AG; Corley DA; Kamineni A; Garcia M; Zheng Y; Doria-Rose PV; Quinn VP; Jensen CD; Chubak J; Tiro J; Doubeni CA; Ghai NR; Skinner CS; Wernli K; Halm EA
    Am J Gastroenterol; 2018 May; 113(5):746-754. PubMed ID: 29487413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes.
    Fendrick AM; Fisher DA; Saoud L; Ozbay AB; Karlitz JJ; Limburg PJ
    Cancer Prev Res (Phila); 2021 Sep; 14(9):845-850. PubMed ID: 34021023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Finding the Right FIT": Rural Patient Preferences for Fecal Immunochemical Test (FIT) Characteristics.
    Pham R; Cross S; Fernandez B; Corson K; Dillon K; Yackley C; Davis MM
    J Am Board Fam Med; 2017; 30(5):632-644. PubMed ID: 28923816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat Annual Colorectal Cancer Screening in Rural Community Clinics: A Randomized Clinical Trial to Evaluate Outreach Strategies to Sustain Screening.
    Davis TC; Rademaker A; Morris J; Ferguson LA; Wiltz G; Arnold CL
    J Rural Health; 2020 Jun; 36(3):307-315. PubMed ID: 31523848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multilevel, low literacy dual language intervention to promote colorectal cancer screening in community clinics in Florida: A randomized controlled trial.
    Christy SM; Sutton SK; Abdulla R; Boxtha C; Gonzalez P; Cousin L; Ewing A; Montoya S; Lopez D; Beehler T; Sanchez J; Carvajal R; Meade CD; Gwede CK
    Prev Med; 2022 May; 158():107021. PubMed ID: 35305995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer.
    Nielson CM; Vollmer WM; Petrik AF; Keast EM; Green BB; Coronado GD
    J Gen Intern Med; 2019 Jun; 34(6):978-985. PubMed ID: 30684199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and Facilitators of Colorectal Cancer Screening in a Federally Qualified Health Center (FQHC).
    Ylitalo KR; Camp BG; Umstattd Meyer MR; Barron LA; Benavidez G; Hess B; Laschober R; Griggs JO
    J Am Board Fam Med; 2019; 32(2):180-190. PubMed ID: 30850454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobile messenger-initiated reminders improve longitudinal adherence in a community-based, opportunistic colorectal cancer screening program: A single-blind, crossover randomized controlled study.
    Lam TYT; Wu PI; Tang RSY; Luk AKC; Ng S; Sung JJY
    Cancer; 2021 Mar; 127(6):914-921. PubMed ID: 33216357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of colorectal cancer screening after mailed fecal immunochemical test (FIT) outreach in a newly eligible 45-49-year-old community health center population.
    O'Leary MC; Reuland DS; Correa SY; Moore AA; Malo TL; Tan X; Rohweder CL; Wheeler SB; Brenner AT
    Cancer Causes Control; 2023 Dec; 34(Suppl 1):125-133. PubMed ID: 37300632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial.
    O'Connor EA; Vollmer WM; Petrik AF; Green BB; Coronado GD
    Trials; 2020 Jan; 21(1):91. PubMed ID: 31941527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual and Geospatial Characteristics Associated With Use and Nonuse of the Fecal Immunochemical Test (FIT) for Colorectal Cancer Screening in an Urban Minority Population.
    Ramai D; Etienne D; Ayide G; Fields PJ; Reddy M
    J Clin Gastroenterol; 2019; 53(10):744-749. PubMed ID: 30222644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing a small media intervention to increase colorectal cancer screening in primary care clinics.
    Melvin CL; Vines AI; Deal AM; Pierce HO; Carpenter WR; Godley PA
    Transl Behav Med; 2019 Jul; 9(4):605-616. PubMed ID: 30085287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study.
    Duncan A; Turnbull D; Wilson C; Osborne JM; Cole SR; Flight I; Young GP
    BMC Public Health; 2014 Mar; 14():238. PubMed ID: 24606951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year follow-up of the effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers.
    Baker DW; Brown T; Goldman SN; Liss DT; Kollar S; Balsley K; Lee JY; Buchanan DR
    Cancer Causes Control; 2015 Nov; 26(11):1685-90. PubMed ID: 26337733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.